Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum NetraMark Holdings Inc AINMF


Primary Symbol: C.AIAI

NetraMark Holdings Inc. is a Canada-based company, which is focused on the development of Generative Artificial Intelligence (Gen AI)/Machine Learning (ML) solutions targeted at the pharmaceutical industry. The Company’s product offering uses a novel topology-based algorithm that has the ability to parse patient data sets into subsets of people that are strongly related according to several... see more

CSE:AIAI - Post Discussion

NetraMark Holdings Inc > $MEND CEO interview
View:
Post by StockHawk1 on Nov 22, 2021 4:00pm

$MEND CEO interview

The CEO of Nurosene Health Inc.( $MEND.C $MNNDF ), Ranj Bath, went on The Stock Day Podcat (hosted by Everett Jolly) to discuss the beta launch of Nuro App and the future of the healthcare industry. 


For those who haven't heard of $MEND, their main asset is the Nuro App.


Neuro is a wellness app that finds correlations between physical health patterns and mental health, and creates programs for how users can improve their physical and mental health.  


Some highlights from the interview: 

- Nuro App digitizes the experience of seeing a neurologist and leverages technical advancements in AI to understand the data the app collects from users.

- Bath says there will be multiple revenue paths in 2022 for the Nuro app including partnering with third parties and taking a margin there as well.


If you are invested in $MEND / $MNNDF or thinking about it I would highly recommend listening to the full podcast episode here: https://audioboom.com/posts/7984230-nurosene-health-inc-discusses-beta-launch-of-nuro-app-and-the-future-of-the-healthcare-industry


Currently. $MEND is trading at $1.86 (about 4% down), MC is $61.79M

 
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities